23 December 2020

tranScrip is delighted to welcome Kate Dawson as one of tranScrip’s project management specialists. Kate Dawson

Kate has over 20 years of project and operations experience in a variety of highly regulated industries, including 7 years at GE Healthcare Pharmaceutical Diagnostics, in a role that spanned across Portfolio Operations, R&D Clinical Development, Medical Affairs, Global Operations and Imaging Technology.

She has a particular interest and expertise in Medical Affairs activities including Educational Grants, Investigator Initiated Trials, Congress activity planning, publications approval, Advisory Boards, KOL management etc.

Kate formerly sat on the PMO of AMYPAD, an IMI2-funded European research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of β-amyloid PET imaging. 

Customer centricity drives Kate’s approach to projects.  She is adept at engaging members of cross-functional teams, to ensure focus remains on the end goal. Kate has the necessary skills to oversee objectives, timelines, budget and quality, to proactively risk manage projects.

Kate sits in the Project Management Team at tranScrip. She holds a BSc from University College London, and a Certificate in Small Business Management from Oxford Brookes University.

Flic Gabbay, tranScrip’s Managing Partner said, “We are delighted to have Kate join us, she will be a great asset to our burgeoning project management and operations team. Her medical affairs skills and involvement with the IMI-2 Alzheimers project will also be a considerable asset to all our teams and in particular our CNS team.”